Remarkable advances in the understanding of central nervous system (CNS) tumor initiation, progression, and molecular features continue to shape the field of neurooncology and are beginning to yield the first real advancements in patient care in many years. Improved understanding of tumor pathogenesis directly affects current therapy for many CNS tumors, and that clinical translation is appropriately reflected in both the title and text of this new book in the Current Clinical Oncology series. This concise text, divided into three parts, expertly covers CNS tumors in 22 chapters with the contribution of 58 chapter authors. Although nearly half of the authors are affiliated with Harvard, a reasonable number of major academic institutions in the United States and a few international centers are also represented.
No comments:
Post a Comment